BIOCON LIMITED. (532523) — Latest Corporate Announcements
₹346.6
+₹0.25 (+0.07%)
Market Cap
₹56,764.56 Cr
P/E Ratio
101.64
52W Range
₹337.7 – ₹447.15
Corporate Actions & Regulatory Filings
Biocon Ltd - 532523 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Biocon Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Biocon Limited has informed the Exchange about Disclosure pursuant to Regulation 30 of the SEBI Listing Regulations
Biocon Ltd - 532523 - Disclosure Pursuant To Regulation 30 Of The SEBI Listing Regulations
Biocon Ltd - 532523 - Grant Of Employee Stock Options Under Biocon Unity Long Term Incentive Plan 2026 Read With The Notified Plans Thereunder
Biocon Ltd - 532523 - Company Secretary
Biocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Biocon Ltd - 532523 - Communication Regarding Remittance Of Final Dividend For The FY 2025-26
Biocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Biocon Ltd - 532523 - Communication Regarding Remittance Of Final Dividend For The FY 2025-26
Biocon Ltd - 532523 - Company Statement
To consider and approve the financial results for the period ended Jun 30, 2026
To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve the financial results for the period ended December 31, 2025
To consider and approve the financial results for the period ended September 30, 2025
To consider and approve the financial results for the period ended Jun 30, 2025
To consider and approve the financial results for the period ended March 31, 2025 and dividend
To consider and approve the financial results for the period ended December 31, 2024 and other business matters
To consider and approve the financial results for the period ended September 30, 2024 and other business matters
To consider and approve the financial results for the period ended Jun 30, 2024
Financial Results (Quarterly & Annual)
| Quarter / Period | Meeting / Outcome Date | Status | Filing Details |
|---|---|---|---|
| Quarter Ended 30-Jun-2026 (Q1 FY27) | 05-Aug-2026 | Declared | To consider and approve the financial results for the period ended Jun 30, 2026 |
| Year Ended 31-Mar-2026 (Q4 FY26) | 07-May-2026 | Declared | To consider and approve the financial results for the period ended March 31, 2026 and dividend |
| Quarter Ended 31-Dec-2025 (Q3 FY26) | 12-Feb-2026 | Declared | To consider and approve the financial results for the period ended December 31, 2025 |
| Quarter Ended 30-Sep-2025 (Q2 FY26) | 11-Nov-2025 | Declared | To consider and approve the financial results for the period ended September 30, 2025 |
| Quarter Ended 30-Jun-2025 (Q1 FY26) | 07-Aug-2025 | Declared | To consider and approve the financial results for the period ended Jun 30, 2025 |
| Year Ended 31-Mar-2025 (Q4 FY25) | 08-May-2025 | Declared | To consider and approve the financial results for the period ended March 31, 2025 and dividend |
| Quarter Ended 31-Dec-2024 (Q3 FY25) | 30-Jan-2025 | Declared | To consider and approve the financial results for the period ended December 31, 2024 and other business matters |
| Quarter Ended 30-Sep-2024 (Q2 FY25) | 30-Oct-2024 | Declared | To consider and approve the financial results for the period ended September 30, 2024 and other business matters |
| Quarter Ended 30-Jun-2024 (Q1 FY25) | 08-Aug-2024 | Declared | To consider and approve the financial results for the period ended Jun 30, 2024 |
| Year Ended 31-Mar-2024 (Q4 FY24) | 16-May-2024 | Declared | To consider and approve the financial results for the period ended March 31, 2024 and dividend |
| Quarter Ended 31-Dec-2023 (Q3 FY24) | 08-Feb-2024 | Declared | To consider and approve the financial results for the period ended December 31, 2023 |
| Quarter Ended 30-Sep-2023 (Q2 FY24) | 10-Nov-2023 | Declared | To consider and approve the financial results for the period ended September 30, 2023 |
Track Related Peer Equities
Related Research Guides & Regulatory Playbooks
Frequently Asked Questions about BIOCON LIMITED. BSE Disclosures
What is the latest BSE announcement by BIOCON LIMITED.?
The latest BSE disclosure by BIOCON LIMITED. (BIOCON), filed on 2026-10-12T20:22:15, is: "Biocon Ltd - 532523 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018". Bsenexus tracks every official filing for BIOCON LIMITED. with AI-powered summaries on its announcements feed.
When is BIOCON LIMITED.'s next board meeting?
No upcoming board meeting is currently tracked for BIOCON LIMITED.. Companies disclose meeting intimations under SEBI LODR, and scheduled dates appear on the Bsenexus Results Calendar.
When does BIOCON LIMITED. declare quarterly results?
Under SEBI (LODR) Regulation 33, listed companies submit quarterly unaudited results within 45 days of the quarter ending, and annual audited figures within 60 days. BIOCON LIMITED.'s recent results history is tabulated above. Track scheduled board meetings on the Bsenexus Results Calendar.